Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

S4 Capital scales back revenue guidance after tough first half

(Sharecast News) - Media company S4 Capital has cut its full-year sales targets after a challenging first half, but said it is considering raising its dividend if the second half picks up as expected. The company, which confirmed last month that it was in discussions about a potential merger with MSQ Partners, said that full-year like-for-like revenues are now expected to fall at a mid-single-digit percentage rate, compared with guidance in June for a low-single-digit decline.

Guidance for profits - operational EBITDA is expected to be broadly similar to 2024 - was left unchanged and is predicted to have a greater second-half weighting due to the timing of significant new business wins and cost reductions.

Net revenues for the six months to 30 June were down 12.7% £328.2m, falling 10% on a LFL basis, which S4 Capital said reflected the impact of macro conditions - specifically the uncertainty surrounding eventual tariff levels - on client confidence.

"Clients remain generally cautious given this uncertainty, with technology clients in particular, which account for almost half our revenue, continuing to prioritise capital expenditure on expanding AI capacity. Technology Services faced longer sales cycles and continues to be affected by a reduction in one of our larger relationships, although this will cycle out in the second half of the year," the company said.

Operational EBITDA was down 30.9% at £20.8m, though in line with expectations, the company said.

S4 Capital, which paid its maiden dividend last year, is not proposing an interim dividend but will consider an enhanced final dividend for 2025, "if the improved second half performance and liquidity targets are delivered".

S4 Capital said on 11 August that it had received a proposal from MSQ Partners, which is majority owned by One Equity Partners, about a "possible combination", though talks were at a very preliminary stage. If agreed, the deal would be structured as an acquisition of MSQ by S4 Capital.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.